Literature DB >> 10919007

Hepatocellular carcinoma in Mansoura-Egypt: experience of 385 patients at a single center.

M Abdel-Wahab1, A A el-Enein, M Abou-Zeid, A el-Fiky, T Abdallah, M Fawzy, A Fouad, A Sultan, O Fathy, G el-Ebidy, N elghawalby, F Ezzat.   

Abstract

BACKGROUND/AIMS: Hepatocellular carcinoma is one of the commonest malignancies in the world. The two main etiological factors for hepatocellular carcinoma are cirrhosis and viral hepatitis. Although the first choice of treatment for hepatocellular carcinoma is surgical resection, most of them are unresectable at the time of diagnosis.
METHODOLOGY: From January 1994 to June 1999, 385 patients with hepatocellular carcinoma were presented to the Gastroenterology surgical center, Mansoura University, Egypt and subjected to similar diagnostic process. Forty-five (11.6%) of these patients (34 males and 13 females) with a mean age of 50.9 years (+/- 7.53 years) were subjected to different types of hepatic resection.
RESULTS: The underlying liver pathology was cirrhosis in 85%. Positive virology was found in 82.5% (HCV 61%, HBV 14.5% and combined 7%). The main presentation were asymptomatic in 144 (37.4%) patients, abdominal pain in 92 (23.9%) patients, ascites in 95 (24.6%) patients, jaundice in 53 (14%) patients and upper gastrointestinal hemorrhage in 26 (6.75%) patients. Only 45 (11.6%) were resectable, they were subjected to hepatic resection with operative mortality in 2 cases (4.4%) and with overall mortality in 29 (64.4%) cases after 48 months (32.8 +/- 19 months) of follow-up. The main causes of late mortality were recurrence in 14 (31.1%) cases, hepatic cell failure in 7 (15.5%) cases and other causes in 6 (13.3%).
CONCLUSIONS: Hepatocellular carcinoma is now a common malignancy in Egypt, which usually develops on top of cirrhosis of viral origin in 82%. Hepatic resection is the only method of treatment with a low resectability rate.

Entities:  

Mesh:

Year:  2000        PMID: 10919007

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Hepatitis C virus and other risk factors in hepatocellular carcinoma.

Authors:  E Schiefelbein; A-R Zekri; D W Newton; G A Soliman; M Banerjee; Ch-W Hung; I A Seifeldin; A-Ch Lo; A S Soliman
Journal:  Acta Virol       Date:  2012       Impact factor: 1.162

2.  Androgen profiles among Egyptian adults considering liver status.

Authors:  Cristina E Aguilar; Amr S Soliman; Daniel S McConnell; Abdel-Rahman Zekri; Mousumi Banerjee; Ayman Omar; Mohamed Sharawy; Sherif Omar; Ahmed Raouf; Maryfran R Sowers
Journal:  J Gastroenterol Hepatol       Date:  2007-05-24       Impact factor: 4.029

3.  Optimizing the Diagnostic Role of Alpha-Fetoprotein and Abdominal Ultrasound by Adding Overexpressed Blood mRNA Matrix Metalloproteinase-12 for Diagnosis of HCV-Related Hepatocellular Carcinoma.

Authors:  Esam Elshimi; Mostafa Abdel-Samed Mostafa Sakr; Wesam Saber Morad; Lobna Mohammad
Journal:  Gastrointest Tumors       Date:  2019-01-09

4.  Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis.

Authors:  Omar Elshaarawy; Aya Aman; Hazem Mohamed Zakaria; Talaat Zakareya; Asmaa Gomaa; Esam Elshimi; Eman Abdelsameea
Journal:  World J Gastrointest Oncol       Date:  2021-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.